Bioinformatics analysis revealed that the effects of AS3MT on epilepsy likely involved multiple targets including MTHFR, GSTM1, CYP17A1, NT5C2, YBX3, CNNM2, CACNB2, and TRIM26. Here, MTHFR is linked to epilepsy.